426 related articles for article (PubMed ID: 6230668)
21. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21).
Esparza I; Becherer JD; Alsenz J; De la Hera A; Lao Z; Tsoukas CD; Lambris JD
Eur J Immunol; 1991 Nov; 21(11):2829-38. PubMed ID: 1834472
[TBL] [Abstract][Full Text] [Related]
22. The complement fragment C3d facilitates phagocytosis by monocytes.
Gaither TA; Vargas I; Inada S; Frank MM
Immunology; 1987 Nov; 62(3):405-11. PubMed ID: 3499379
[TBL] [Abstract][Full Text] [Related]
23. Proliferation of resting B cells is modulated by CR2 and CR1.
Fingeroth JD; Heath ME; Ambrosino DM
Immunol Lett; 1989 Jun; 21(4):291-301. PubMed ID: 2527816
[TBL] [Abstract][Full Text] [Related]
24. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.
Carel JC; Frazier B; Ley TJ; Holers VM
J Immunol; 1989 Aug; 143(3):923-30. PubMed ID: 2473114
[TBL] [Abstract][Full Text] [Related]
25. Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor.
Pernegger G; Schulz TF; Hosp M; Myones BL; Petzer AL; Eigentler A; Böck G; Wick G; Dierich MP
Immunology; 1988 Oct; 65(2):237-41. PubMed ID: 2461345
[TBL] [Abstract][Full Text] [Related]
26. Evidence for three binding sites for C3 (hemolytically inactive), C3b and C3d on a CR2-positive Burkitt lymphoma-derived cell line (Raji).
Barile G; Di Renzo L; Lipari M; Frati L; Faggioni A
FEBS Lett; 1993 Jun; 324(3):319-24. PubMed ID: 8405374
[TBL] [Abstract][Full Text] [Related]
27. Structural and functional analysis of CR2/EBV receptor by means of monoclonal antibodies and limited tryptic digestion.
Petzer AL; Schulz TF; Stauder R; Eigentler A; Myones BL; Dierich MP
Immunology; 1988 Jan; 63(1):47-53. PubMed ID: 2448232
[TBL] [Abstract][Full Text] [Related]
28. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line.
Hatzfeld A; Fischer E; Levesque JP; Perrin R; Hatzfeld J; Kazatchkine MD
J Immunol; 1988 Jan; 140(1):170-5. PubMed ID: 2826586
[TBL] [Abstract][Full Text] [Related]
29. Complement receptors on Raji cells. The presence of a new type of C3 receptor.
Okuda T; Tachibana T
Immunology; 1980 Sep; 41(1):159-66. PubMed ID: 7429548
[TBL] [Abstract][Full Text] [Related]
30. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor.
Kinoshita T; Thyphronitis G; Tsokos GC; Finkelman FD; Hong K; Sakai H; Inoue K
Int Immunol; 1990; 2(7):651-9. PubMed ID: 1703784
[TBL] [Abstract][Full Text] [Related]
31. gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor.
Frade R; Barel M; Ehlin-Henriksson B; Klein G
Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1490-3. PubMed ID: 2983347
[TBL] [Abstract][Full Text] [Related]
32. Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface.
Guthridge JM; Young K; Gipson MG; Sarrias MR; Szakonyi G; Chen XS; Malaspina A; Donoghue E; James JA; Lambris JD; Moir SA; Perkins SJ; Holers VM
J Immunol; 2001 Nov; 167(10):5758-66. PubMed ID: 11698449
[TBL] [Abstract][Full Text] [Related]
33. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
[TBL] [Abstract][Full Text] [Related]
34. Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.
Delcayre AX; Salas F; Mathur S; Kovats K; Lotz M; Lernhardt W
EMBO J; 1991 Apr; 10(4):919-26. PubMed ID: 1849076
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus/complement fragment C3d receptor (CR2) reacts with p53, a cellular antioncogene-encoded membrane phosphoprotein: detection by polyclonal anti-idiotypic anti-CR2 antibodies.
Barel M; Fiandino A; Lyamani F; Frade R
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10054-8. PubMed ID: 2557614
[TBL] [Abstract][Full Text] [Related]
36. Purification of the B lymphocyte receptor for the C3d fragment of complement and the Epstein-Barr virus by monoclonal antibody affinity chromatography, and assessment of its functional capacities.
Weis JJ; Richards SA; Smith JA; Fearon DT
J Immunol Methods; 1986 Aug; 92(1):79-87. PubMed ID: 3018085
[TBL] [Abstract][Full Text] [Related]
37. The role of receptors for complement in the induction of polyclonal B-cell proliferation and differentiation.
Tedder TF; Weis JJ; Clement LT; Fearon DT; Cooper MD
J Clin Immunol; 1986 Jan; 6(1):65-73. PubMed ID: 3485654
[TBL] [Abstract][Full Text] [Related]
38. Coupling of C3b to erythrocytes by disulfide bond formation: preparation of EC3b for hemolytic and complement receptor assays.
Lambris JD; Scheiner O; Schulz TF; Alsenz J; Dierich MP
J Immunol Methods; 1983 Dec; 65(3):277-83. PubMed ID: 6197481
[TBL] [Abstract][Full Text] [Related]
39. Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21).
Clemenza L; Isenman DE
J Immunol; 2000 Oct; 165(7):3839-48. PubMed ID: 11034390
[TBL] [Abstract][Full Text] [Related]
40. The generation of active fragments of complement receptor type 2 by trypsin digestion.
Micklem K; Sim E; Sim RB
FEBS Lett; 1985 Sep; 189(2):195-201. PubMed ID: 3876241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
